Sjogren Syndrome
📧 Sign up to get email alerts when something new happens for Sjogren Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Update: Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome [Phase 3]
Phase 3 trial of ianalumab (VAY736) in active Sjogren's syndrome completed.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome [Phase 3]
Phase 3 trial assessing efficacy and safety of ianalumab (VAY736) for active Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. [Phase 3]
A Phase 3 randomized trial followed by open-label extension evaluating long-term safety and efficacy of ianalumab in Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Efficacy and Safety of Baricitinib in Sjogren's Syndrome [Phase 2]
Phase 2 trial evaluating efficacy and safety of baricitinib in Sjogren's syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome [Phase 1, Phase 2]
A phase 1/2 clinical trial update reports safety data for tofacitinib, an oral JAK inhibitor, in patients with Sjogren's syndrome, with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome [Phase 3]
Phase 3 study evaluating the efficacy and safety of Telitacicept in active Primary Sjogren's Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome [Phase 1]
Phase 1 clinical trial update reports safety and tolerability findings for the investigational therapy IBI355 in patients with primary Sjogr…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of Cenegermin (Oxervate) versus vehicle for severe Sjogren's dry eye disease has completed, wit…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of VAY736 in patients with primary Sjogren's syndrome has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Fish Oil (Omega 3 ) in Sjogren's Syndrome [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating fish oil (omega-3) in Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia [Phase 3]
Phase 3 clinical trial evaluating a mixture of natural products as salivary substitutes for xerostomia in Sjogren's syndrome; study complete…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS [Phase 2, Phase 3]
A phase 2/3 trial evaluating tacrolimus plus glucocorticoid for severe thrombocytopenia in Sjogren syndrome with other organ involvement is …
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome [Phase 2]
A Phase 2 clinical trial evaluating anifrolumab for 24 weeks in patients with Sjögren's syndrome.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye [Phase 3]
Phase 3 trial update on platelet-rich plasma injections for severe dry eye, including Sjogren syndrome; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder [Phase 4]
Phase 4 clinical trial update investigating a beta-3 agonist and an anti-muscarinic agent for Sjogren's syndrome with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome [Phase 2]
Phase 2 trial evaluating safety and efficacy of subcutaneous belimumab with intravenous rituximab co-administration in primary Sjögren's syn…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Sjogrens Syndrome Measured by Ultrasound [Phase 2]
Phase 2 clinical trial update assessing ultrasound-based measurements in Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome [Phase 2]
Phase 2 clinical trial of RSLV-132 in subjects with primary Sjögren's syndrome has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease [Phase 4]
Phase 4 safety study evaluating topical cyclosporine for dry eye disease, involving patients with Sjögren-related dry eye.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: TrueTear in Sjogren's Disease Patients [NA]
Clinical trial update for TrueTear in Sjogren's syndrome-associated dry eye has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome [Phase 3]
Phase 3 clinical trial update evaluating oral pilocarpine for the treatment of dry eye in patients with Sjögren's syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome [Phase 4]
Phase 4 trial investigating cyclosporine A for interstitial pneumonitis associated with Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome [Phase 2]
A Phase 2 study evaluating safety and efficacy of filgotinib, lanraplenib, and tirabrutinib in adults with active Sjogren's syndrome has com…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome [Phase 3]
A Phase 3 trial comparing topical tacrolimus 0.03% versus cyclosporine 0.05% in dry eye associated with Sjogren syndrome has completed.